List of Tables
Table 1. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Therapeutic Proteins for Cardiovascular Disorders Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Therapeutic Proteins for Cardiovascular Disorders Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Therapeutic Proteins for Cardiovascular Disorders Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Therapeutic Proteins for Cardiovascular Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Proteins for Cardiovascular Disorders Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Type (2019-2024)
Table 59. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Type (2025-2030)
Table 60. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Application (2019-2024)
Table 69. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Eli Lilly & Company Corporation Information
Table 76. Eli Lilly & Company Description and Business Overview
Table 77. Eli Lilly & Company Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eli Lilly & Company Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 79. Eli Lilly & Company Recent Developments/Updates
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Roche Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 84. Roche Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Bristol Myers Squibb Corporation Information
Table 91. Bristol Myers Squibb Description and Business Overview
Table 92. Bristol Myers Squibb Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Bristol Myers Squibb Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 94. Bristol Myers Squibb Recent Developments/Updates
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sanofi Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Merck Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 104. Merck Recent Developments/Updates
Table 105. Amgen Corporation Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Amgen Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 109. Amgen Recent Developments/Updates
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Novartis Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 114. Novartis Recent Developments/Updates
Table 115. Siemens Healthineers Corporation Information
Table 116. Siemens Healthineers Description and Business Overview
Table 117. Siemens Healthineers Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Siemens Healthineers Therapeutic Proteins for Cardiovascular Disorders Treatment Product
Table 119. Siemens Healthineers Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Therapeutic Proteins for Cardiovascular Disorders Treatment Distributors List
Table 123. Therapeutic Proteins for Cardiovascular Disorders Treatment Customers List
Table 124. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Trends
Table 125. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Drivers
Table 126. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Challenges
Table 127. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Therapeutic Proteins for Cardiovascular Disorders Treatment
Figure 2. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Share by Type in 2023 & 2030
Figure 4. Monoclonal Antibodies Proteins Product Picture
Figure 5. Peptides Proteins Product Picture
Figure 6. Peptide Fragments Proteins Product Picture
Figure 7. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Share by Application in 2023 & 2030
Figure 9. Heart Failure
Figure 10. Myocardial Infarction
Figure 11. Arrhythmias
Figure 12. Coronary Artery Disease
Figure 13. Ischemic Heart Disease
Figure 14. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size (2019-2030) & (US$ Million)
Figure 16. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Sales (2019-2030) & (K Units)
Figure 17. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Average Price (USD/Unit) & (2019-2030)
Figure 18. Therapeutic Proteins for Cardiovascular Disorders Treatment Report Years Considered
Figure 19. Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Share by Manufacturers in 2023
Figure 20. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Therapeutic Proteins for Cardiovascular Disorders Treatment Players: Market Share by Revenue in 2023
Figure 22. Therapeutic Proteins for Cardiovascular Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 25. North America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 29. Europe Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 30. Germany Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Region (2019-2030)
Figure 37. China Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 48. Latin America Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Therapeutic Proteins for Cardiovascular Disorders Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Type (2019-2030)
Figure 58. Global Revenue Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Type (2019-2030)
Figure 59. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Application (2019-2030)
Figure 61. Global Revenue Market Share of Therapeutic Proteins for Cardiovascular Disorders Treatment by Application (2019-2030)
Figure 62. Global Therapeutic Proteins for Cardiovascular Disorders Treatment Price (USD/Unit) by Application (2019-2030)
Figure 63. Therapeutic Proteins for Cardiovascular Disorders Treatment Value Chain
Figure 64. Therapeutic Proteins for Cardiovascular Disorders Treatment Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed